DrugPatentWatch Database Preview

INTRON A Drug Profile

« Back to Dashboard

Summary for Tradename: INTRON A

Patents:	1251
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for INTRON A
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for INTRON A

Recent Clinical Trials for INTRON A

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Editas Medicine, Inc.	Phase 1/Phase 2
Allergan	Phase 1/Phase 2
RWTH Aachen University	Phase 2

See all INTRON A clinical trials

Recent Litigation for INTRON A

Identify key patents and potential future biosimilar entrants

District Court Litigation

Case Name	Date
Bay State Milling Company v. Arcadia Biosciences, Inc.	2019-04-01
Boston Heart Diagnostics Corporation v. MD Labs, Inc.	2018-01-05
Boston Heart Diagnostics Corporation v. GeneAlign, LLC	2017-08-01

See all INTRON A litigation

PTAB Litigation

Petitioner	Date
Regeneron Pharmaceuticals, Inc.	2019-09-20
Baylor College of Medicine	2018-04-18
Guardant Health, Inc.	2017-05-17

See all INTRON A litigation

Pharmacology for INTRON A

Ingredient-type

Interferon Alfa-2b Interferon-alpha

Company Disclosures: US Patents for INTRON A

These patents were extracted from company disclosures

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		Schering Corporation (Madison, NJ)	2002-11-19	RX		company
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		Biogen N.V. (Curacao, AN)	2002-07-23	RX		company
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		Schering Corporation (Kenilworth, NJ)	2039-03-29	RX		company
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		Schering Corporation (Kenilworth, NJ)	2014-10-11	RX		company
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA)	2020-08-26	RX		company

Patent Text Search: US Patents for INTRON A

These patents were identified by searching patent claims

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		IDENIX PHARMACEUTICALS LLC (Cambridge, MA)	2039-02-26	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		Cipla Limited (Mumbia, IN)	2035-12-09	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		YALE UNIVERSITY (New Haven, CT)	2021-05-01	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04		ANDES BIOTECHNOLOGIES GLOBAL, INC. (Burlingame, CA)	2033-03-14	RX		search

International Patents for INTRON A

Country	Patent Number	Estimated Expiration
Israel	133847
Spain	2162833
Japan	2008513030
Argentina	003112
Japan	2001190289

Supplementary Protection Certificates for INTRON A

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2003C/006	Belgium		PRODUCT NAME: MOROCTOCOG ALFA; REGISTRATION NO/DATE: EU/1/99/103/001 19990413
91087	Luxembourg		91087, EXPIRES: 20100111
122017000100	Germany		PRODUCT NAME: NUSINERSEN ODER SALZE DAVON (INTERNATIONALER, NICHT FIRMENEIGENER NAME); REGISTRATION NO/DATE: EU/1/17/1188 20170530
CA 2017 00055	Denmark		PRODUCT NAME: NUSINERSEN ELLER SALTE DERAF; REG. NO/DATE: EU/1/17/1188 20170601
C201730053	Spain		PRODUCT NAME: NUSINERSEN O SUS SALES; NATIONAL AUTHORISATION NUMBER: EU/1/17/1188; DATE OF AUTHORISATION: 20170530; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1188; DATE OF FIRST AUTHORISATION IN EEA: 20170530